| Jeffrey P Lawrence, MD | |
|
134 Franklin Rd, Brentwood, TN 37027-4685 | |
| (615) 236-5000 | |
| (615) 236-5005 |
| Full Name | Jeffrey P Lawrence |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 41 Years |
| Location | 134 Franklin Rd, Brentwood, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760473987 | NPI | - | NPPES |
| 3010150 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 15322 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tristar Centennial Medical Center | Nashville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Orthopaedic Alliance Pa | 5193625069 | 308 |
News Archive
Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.
The thrill of delivering newborns helped pull Dr. Jack Feltz into the field of obstetrics and gynecology.
The very first successful organ donation from a newborn carried out in the UK is reported in the Fetal & Neonatal Edition of Archives of Disease in Childhood.
Pregnant women with type 1 diabetes run a higher risk of having babies with heart defects, especially women with high blood glucose levels during early pregnancy, a study from Karolinska Institutet and the Sahlgrenska Academy in Sweden published in The BMJ shows.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented data on PV-10 combination therapy today at the American Association for Cancer Research Annual Meeting in Washington, DC.
› Verified 8 days ago
| Entity Name | Tennessee Orthopaedic Alliance Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538153937 PECOS PAC ID: 5193625069 Enrollment ID: O20040109000069 |
News Archive
Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.
The thrill of delivering newborns helped pull Dr. Jack Feltz into the field of obstetrics and gynecology.
The very first successful organ donation from a newborn carried out in the UK is reported in the Fetal & Neonatal Edition of Archives of Disease in Childhood.
Pregnant women with type 1 diabetes run a higher risk of having babies with heart defects, especially women with high blood glucose levels during early pregnancy, a study from Karolinska Institutet and the Sahlgrenska Academy in Sweden published in The BMJ shows.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented data on PV-10 combination therapy today at the American Association for Cancer Research Annual Meeting in Washington, DC.
› Verified 8 days ago
| Entity Name | Select Health Of Sc, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962904946 PECOS PAC ID: 7416212972 Enrollment ID: O20210623003548 |
News Archive
Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.
The thrill of delivering newborns helped pull Dr. Jack Feltz into the field of obstetrics and gynecology.
The very first successful organ donation from a newborn carried out in the UK is reported in the Fetal & Neonatal Edition of Archives of Disease in Childhood.
Pregnant women with type 1 diabetes run a higher risk of having babies with heart defects, especially women with high blood glucose levels during early pregnancy, a study from Karolinska Institutet and the Sahlgrenska Academy in Sweden published in The BMJ shows.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented data on PV-10 combination therapy today at the American Association for Cancer Research Annual Meeting in Washington, DC.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey P Lawrence, MD Po Box 306556, Nashville, TN 37230-6556 Ph: (615) 329-2294 | Jeffrey P Lawrence, MD 134 Franklin Rd, Brentwood, TN 37027-4685 Ph: (615) 236-5000 |
News Archive
Medical diagnostics company Biomoda, Inc. is taking preliminary steps to launch multisite Phase III clinical trials of its in-vitro diagnostic for early-stage lung cancer, trademarked under the name CyPath®.
The thrill of delivering newborns helped pull Dr. Jack Feltz into the field of obstetrics and gynecology.
The very first successful organ donation from a newborn carried out in the UK is reported in the Fetal & Neonatal Edition of Archives of Disease in Childhood.
Pregnant women with type 1 diabetes run a higher risk of having babies with heart defects, especially women with high blood glucose levels during early pregnancy, a study from Karolinska Institutet and the Sahlgrenska Academy in Sweden published in The BMJ shows.
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented data on PV-10 combination therapy today at the American Association for Cancer Research Annual Meeting in Washington, DC.
› Verified 8 days ago
James Bartley Mcgehee Iii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 134 Franklin Rd, Brentwood, TN 37027 Phone: 615-236-5000 Fax: 615-236-5005 | |
William Bailey Kurtz Ii, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 134 Franklin Rd, Brentwood, TN 37027 Phone: 615-236-5000 Fax: 615-236-5005 |